Sign up Australia
Proactive Investors - Run By Investors For Investors
Why invest in NMT?
Neometals Ltd: THE INVESTMENT CASE
INVESTMENT OVERVIEW

Neometals viewed as substantially undervalued as it moves to near-term profitability

The company will be turning a profit as plenty of other players in the sector are a long way from generating first revenues.
Picture of map of projects
INVESTMENT OVERVIEW: NMT The Big Picture
Arlington's sum of the parts valuation of $1.43 implies upside of about 360% to the company’s recent trading range

Neometals Ltd (ASX:NMT) has dispatched a 53-tonne bulk sample from its Barrambie Titanium Vanadium deposit in Western Australia as it prepares for a direct shipping ore (DSO) operation. 

The sample targeted typical high-grade titanium and vanadium mineralisation from the eastern band of the deposit, which is potentially the main feed source for the planned DSO operation.

READ: Neometals sends titanium vanadium bulk sample to China for potential offtake partners

This is an important development in accessing Chinese markets, as it should confirm the optimal pathway for the extraction of titanium, vanadium and iron products.

The results of these tests will form a basis to negotiate offtake pricing.

Chief executive officer Chris Reed said: “As we progress the dual track evaluation of DSO and integrated titanium/vanadium chemical production, it is critical we give comfort to potential Chinese customers of the quality and value of the Barrambie DSO product.”

A truly diversified asset rich company

However, there is much more to Neometals than the Barrambie project and looking across the company’s range of assets, its market capitalisation of $170 million appears conservative.

It was only in mid-April that Neometals released a 48,200-tonne nickel resource within the Mt Edwards lithium project in Western Australia.

READ: Neometals reveals nickel JORC resource at Mt Edwards

The March acquisition of this brownfields lithium exploration project appeared to slip under the radar.

While it is arguably a sleeper in Neometals’ impressive portfolio of assets, expect ongoing newsflow given the highly prospective location just 40 kilometres south of Mt Marion.

Arlington sees share price upside of 360%

Indeed, Mark Fernley from the UK-based Arlington Group views the company as substantially undervalued.

His sum of the parts valuation of $1.43 implies upside of about 360% to the company’s recent trading range.

The broker recently reflected on the meshing together of Neometals’ Mt Marion lithium operation and its potential to assist in developing Barrambie.

Mt Marion complementary to Barrambie

Fernley said: “NMT’s 13.8% share in the Mt Marion lithium mine should continue to yield strong cash flow for many years.

“This should potentially allow NMT to develop the Barrambie titanomagnetite DSO project and continue to develop the associated titanium dioxide (TiO2) project.

“The lithium hydroxide (LiOH) plant is a positive addition to this.”

Fundamentals speak for themselves

Certainly, the projected financials support Fernley’s take on the company.

He is forecasting a maiden profit of $52 million as early as fiscal 2019.

Bear in mind there are plenty of other players in the sector that are a long way from generating first revenues, let alone turning a profit.

The forecast profit equates to earnings per share of 10 cents, implying a PE multiple of three relative to the company’s current trading range.

Production ramp up at Mt Marion continues

The other major shareholders involved in the Mt Marion project are Mineral Resources Ltd (ASX:MIN) and Ganfeng Lithium Co Ltd (SHE:002460), with each having a stake of 43.1%.

There were shipments of lithium concentrates to Ganfeng during the quarter with nearly 84,000 tonnes dispatched during the quarter.

March was a particularly strong month as nearly 54,000 tonnes were shipped.

Construction of the upgrade to the concentrator circuits to facilitate production of all 6% lithium concentrate is expected to be completed in the December quarter.

Extracting more value from Mt Marion

Neometals continues to assess the development of a lithium processing facility close to the Mt Marion lithium operation.

The company has retained its binding offtake option right for a minimum of 12.37% of production from Mt Marion from February 2020.

This would provide a secure supply of feedstock to support the prospective development of its own downstream processing plant.

Equipment test work completed

Neometals has completed the vendor equipment test work in North America, which was in line with the group’s upbeat expectations.

The tests confirmed that proposed process flow sheet and high-quality product analysis (99.99% lithium hydroxide monohydrate).

This data will assist in the front-end engineering design (FEED) study which was launched at the start of May.

Plant to be located in Kalgoorlie

The lithium hydroxide plant is proposed to be built in Kalgoorlie.

READ: Neometals to begin FEED study for lithium hydroxide project

The FEED study should be completed by the end of 2018, and the project feasibility study will integrate these results in preparation for an investment decision in the first quarter of 2019.

Commenting on this development, Reed said: “Neometals looks forward to advancing its strategy to become an integrated lithium producer and maximise the value of its spodumene offtake rights from Mt Marion via the downstream conversion to lithium hydroxide in the local plant.”

View full NMT profile View Profile

Neometals Ltd Timeline

Related Articles

miner
February 20 2018
South Korea is the most supportive jurisdiction Bluebird's team has operated
gold
April 03 2018
Stratex is now under the tutelage of a new, experienced chief executive and on the lookout for opportunities
1523885547_shutterstock_130697096.jpg
April 16 2018
Pan African now is moving on from operational issues, with production at Barberton set to rise significantly this year

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use